EMERALD-3: tremelimumab + durvalumab with or without lenvatinib combined with TACE in HCC VJOncology 2:33 1 year ago 467 Далее Скачать
HIMALAYA: tremelimumab + durvalumab in unresectable HCC VJOncology 4:56 2 years ago 1 103 Далее Скачать
HIMALAYA: Does underlying liver function impact efficacy of tremelimumab plus durvalumab for HCC? VJOncology 3:34 2 years ago 448 Далее Скачать
Dr. Balar on Impact of Durvalumab Plus Tremelimumab in Bladder Cancer OncLive 1:07 6 years ago 209 Далее Скачать
HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients with uHCC ecancer 7:48 2 years ago 873 Далее Скачать
INFINTY: tremelimumab and durvalumab in MSI-high GC/GEJC VJOncology 3:26 1 year ago 119 Далее Скачать
MONTBLANC: sequential or up-front durvalumab, tremelimumab, + bevacizumab in unresectable HCC VJOncology 1:15 8 months ago 112 Далее Скачать
POSEIDON: 4 year follow up of durvalumab and tremelimumab in NSCLC VJOncology 2:10 2 years ago 1 407 Далее Скачать
HIMALAYA: tremelimumab + durvalumab in unresectable HCC VJOncology 4:56 2 years ago 436 Далее Скачать
ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone GRACE - Global Resource for Advancing Cancer Education 6:38 2 years ago 592 Далее Скачать
Katie Kelley, MD, discusses fitting tremelimumab + durvalumab into HCC treatment algorithms OBRoncology 3:57 4 years ago 138 Далее Скачать
INFINITY: neoadjuvant or definitive tremelimumab with durvalumab in MSI GAC/GEJAC VJOncology 1:07 3 months ago 38 Далее Скачать
Dr. Sonpavde Discusses a Study of Fixed-Dose Durvalumab and Tremelimumab in Urothelial Carcinoma OncLive 1:43 6 years ago 179 Далее Скачать
Tebentafusp in combination with durvalumab and/or tremelimumab in metastatic cutaneous melanoma VJOncology 2:39 2 years ago 819 Далее Скачать
Double immunotherapy with durvalumab and tremelimumab versus quadruple therapy in NSCLC VJOncology 0:43 7 years ago 208 Далее Скачать
AstraZeneca’s Immunotherapy Imjudo (tremelimumab) Wins FDA Approval for Liver Cancer Xtalks 0:42 1 year ago 2 649 Далее Скачать
POSEIDON: durvalumab +/- tremelimumab + chemo in 1L mNSCLC VJOncology 3:48 2 years ago 360 Далее Скачать